The efficacy of ciprofloxacin in preventing infection among patients with chemotherapy induced neutropenia in a university medical center in Ira
Phase 2
- Conditions
- Condition 1: Neutropenia. Condition 2: Fever.AgranulocytosisFever, unspecified
- Registration Number
- IRCT2015092924266N1
- Lead Sponsor
- AJA University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Absolute neutrophil count < 500 or less 1000 with predicted fall to below 500 in 48-72 hours; History of Malignancy.
Exclusion criteria: Fever or Any sign of clinical or microbiological infection; Any history of antibiotic consumption lately before admission.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fever. Timepoint: After intervention. Method of measurement: Body core temperature by Thermometer.
- Secondary Outcome Measures
Name Time Method Bacterial Infection. Timepoint: After intervention. Method of measurement: Blood, urine or sputum culture.